Early in-hospital discontinuation of aspirin on the first post-procedural day after percutaneous coronary stent implantation in patients on direct oral anticoagulation

Early in-hospital discontinuation of aspirin on the first post-procedural day after percutaneous coronary stent implantation in patients on direct oral anticoagulation

BackgroundPrevious trials investigating antithrombotic therapy with a direct oral anticoagulant (DOAC) and a P2Y12 inhibitor after percutaneous coronary intervention (PCI), termed dual therapy, allowed a short period of triple therapy including a DOAC, a P2Y12 inhibitor, and aspirin.AimsThis study a...

Full description

Bibliographic Details
Main Authors: Philipp von Stein, Lukas Seitz, Hendrik Wienemann, Christopher Hohmann, Till Baar, Stephan Baldus, Marcel Halbach
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-12-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
PCI
aspirin
DOAC
triple therapy
dual therapy
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2023.1265452/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2023.1265452/full

Similar Items